Ordinary Adjustment | Solactive Global Big Pharma Index | Effective Date 6th February 2025
Solactive Global Big Pharma Index:
In the ordinary adjustment, the following composition will be implemented effective open 6th February 2025:
ABBVIE INC |
ROCHE HOLDING AG |
ELI LILLY & CO |
BRISTOL-MYERS SQUIBB CO |
MERCK & CO. INC. |
JOHNSON & JOHNSON |
PFIZER INC |
VERTEX PHARMACEUTICALS INC |
GILEAD SCIENCES INC |
AMGEN INC |
ASTRAZENECA PLC-SPONS ADR |
GSK PLC-SPON ADR |
NOVO-NORDISK A/S-SPONS ADR |
NOVARTIS AG-SPONSORED ADR |
SANOFI-ADR |